GlassScriptPhysician profile
Aaron C Teufel
NPI 1609288984
$3,545.23
in general payments reported to CMS, 2019-2025
9 companies · $209 in 2025
The $209 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,560 · 2020: $39.39 · 2022: $13.18 · 2023: $34.35 · 2024: $1,689 · 2025: $209.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,331 · Food and Beverage: $602.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,330.50 |
| Food and Beverage | $601.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $1,344.99 | 2019 | |
| Medical Device Business Services, INC. | $1,178.59 | 2024 | |
| Stryker Corporation | $413.95 | 2019-2025 | Prostep, Easyfuse, Prostep Mica |
| Treace Medical Concepts, INC. | $355.15 | 2024 | |
| Depuy Synthes Sales INC. | $141.78 | 2024 | Motoband, Crosstie |
| Organogenesis INC. | $60.68 | 2022-2024 | Puraply, Affinity |
| Arthrosurface Incorporated | $19.26 | 2019 | |
| Globus Medical, INC. | $17.69 | 2025 | Senza |
| Osiris Therapeutics INC. | $13.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Teufel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.